Recruiting NA Tourette Syndrome

New treatment option for Tourette Syndrome

Official title Remote Delivery of a Mindfulness-based Intervention for Tics

ClinicalTrials.gov ID: NCT06408662

What this study is testing

What it's testing
This research study is being done to compare a mindfulness-based intervention for tics (MBIT) to psychoeducation with relaxation and supportive therapy (PRST) for individuals with Tourette's syndrome or Persistent Tic Disorders (collectively TS). It is the investigator's hope that this information cam be used to improve current treatments for individuals with TS.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • be ≥18 years of age;
  • meet diagnostic criteria for a primary or co-primary diagnosis of Tourette Syndrome or a Persistent Motor or Vocal Tic Disorder on a structured...
  • have moderate or greater tic severity as evidenced by a YGTSS Total Tic Score of \>14 (when motor and vocal tics are present) or \>10 (when only...
  • be medication free and/or on a stable dose of psychiatric medication 8 weeks prior to study participation;
  • be not engaged in psychotherapy for non-TS conditions and/or be on a stable course of therapy for 6 months prior to study participation

You likely can't join if

  • a current diagnosis of substance use disorder, psychosis, mania or another condition that requires another form of care;
  • severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention;
  • concurrent psychotherapy for TS;
  • prior extensive experience with mindfulness and/or meditation.
See the full eligibility criteria
Who can join
  • be ≥18 years of age;
  • meet diagnostic criteria for a primary or co-primary diagnosis of Tourette Syndrome or a Persistent Motor or Vocal Tic Disorder on a structured clinical interview;
  • have moderate or greater tic severity as evidenced by a YGTSS Total Tic Score of \>14 (when motor and vocal tics are present) or \>10 (when only motor or vocal tics are present);
  • be medication free and/or on a stable dose of psychiatric medication 8 weeks prior to study participation;
  • be not engaged in psychotherapy for non-TS conditions and/or be on a stable course of therapy for 6 months prior to study participation
  • be fluent in English;
  • have access to a smart phone and/or tablet.
What rules you out
  • a current diagnosis of substance use disorder, psychosis, mania or another condition that requires another form of care;
  • severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention;
  • concurrent psychotherapy for TS;
  • prior extensive experience with mindfulness and/or meditation.

The study team makes the final eligibility decision.

Where it's taking place

  • Baltimore, Maryland, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.